Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Subspecialties


Subspecialties Cornea / Ocular Surface

Cash Injection

| Phoebe Harkin

From a single cornea to a hundred cell therapy injections: is CorneaGen on course to end our dependence on donor tissue?

Subspecialties Neuro-ophthalmology

Theater of the Mind

| Judith Potts

Raising awareness and understanding of a largely misunderstood condition: the Charles Bonnet Syndrome

Subspecialties Health Economics and Policy

Genetic Lottery

| Aleksandra Jones

When even the world’s wealthiest economies struggle to fund gene therapies, we have a problem that demands disruptive solutions

Subspecialties Cataract

DEXYCU: Jason Bacharach

| Sponsored by EyePoint Pharmaceuticals

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

DEXYCU: Mark Pyfer

| Sponsored by EyePoint Pharmaceuticals

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

A NOD to Affirm Performance

| John Sparrow

The RCOphth National Ophthalmology Database (NOD) Audit can provide richer outcomes analysis than any single individual or institution – and cost less

Subspecialties Glaucoma

In and Out

| Philip Bloom

Could combining inflow and outflow procedures be a new strategy for combating glaucoma?

Subspecialties Refractive

The Refractive Principle

| Arthur Cummings

It is time for ophthalmology to embrace refractive surgery – for the sake of humankind

Subspecialties Cataract

DEXYCU: Michael Savetsky

| Sponsored by EyePoint Pharmaceuticals

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Pediatric

Timely Treatment for ROP

Thanks to European approval of a new indication for Lucentis, preterm infants with ROP finally have a pharmacotherapeutic option

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register